| Ytd | -8.45% | |
| 1y | -13.91% |
| Open | 1.40 | Prev Close | 1.31 | Low | 1.26 | High | 1.46 | Mkt Cap | 37.51M |
| Vol | 189.01K | Avg Vol | 2.95M | EPS | -0.40 | P/E | N/A | Forward P/E | N/A |
| Beta | 2.87 | Short Ratio | 5.12 | Inst. Own | 0.08% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.63 | 200-d Avg | 0.89 | 1yr Est | 0.00 |
iSpecimen surged 27.9% premarket on a $4.5M Foldlab AI asset deal; CEA Industries led gainers, while
Veeco Instruments Inc (NASDAQ: VECO) rose in pre-market trading after reporting Q1 results and affir
CL Workshop Group Ltd (NASDAQ:NWGL) reported quarterly earnings of $0.00 per share. This is a 110 pe
Nature Wood Group Limited (NASDAQ:NWGL) (the "Company"), a global leading vertically-integra
Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the comp
As of March 5, 2024, five stocks in the materials sector could be flashing a real warning to investo
Nature Wood Group Limited Expects 75% Revenue Growth in 2024MACAU, March 4, 2024 /PRNewswire/ -- Nat
Nature Wood Group Limited (NASDAQ:NWGL), a global leader in vertically-integrated forestry and FSC b
Nature Wood Group Limited ("Nature Wood" or the "Company"), a global leader in verti
Nature Wood Group Limited (the "Company" or "Nature Wood") (NASDAQ:NWGL), a global l
Gainers Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares surged 68% to $0.2075. Avalo Therapeutics
Gainers Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares rose 38.7% to $0.1713 in pre-market tradin